Garrett Graff, partner and member of the firm’s Cannabis and Hemp Group, recently spoke with Josh Long at National Products Insider about delta-8 THC products and its inclusion in the 2018 Farm Bill.
The article, Delta-8 THC Raises Questions About Intent of Farm Bill, was published on July 23 in National Products Insider, an Informa-owned publication. An excerpt from the article is below.
Arguments over the intent of Congress in legalizing hemp in 2018 may be academic at this point since leading Democrats recently moved to end the prohibition on marijuana. Still, the proliferation of delta-8 THC products could undermine efforts to create a lawful pathway for CBD in conventional food and supplements, a prominent hemp lawyer said, citing fears of some congressional staff.
Delta-8 THC products are in high demand in the U.S., but several attorneys who counsel businesses in the hemp industry said in interviews that members of Congress didn’t intend to legalize psychoactive or intoxicating compounds in the 2018 Farm Bill.
Unlike hemp, marijuana typically contains large quantities of delta-9 THC. State-regulated cannabis dispensaries have potency limits on marijuana, yet the likes of gas stations may be selling more powerful delta-8 THC products than legal marijuana, observed Garrett Graff, a partner with the law firm Moye White, who focuses on hemp and broader cannabis issues.
Graff said he questions “rhetorically or facetiously” whether McConnell would testify that was his intent.
About Moye White LLP
Moye White is a full-service business law firm serving clients throughout the United States and internationally, with offices in Colorado and Georgia. The firm provides legal representation to clients in a wide variety of industries offering strategic, business-oriented counsel to public, private, and governmental clients in complex business and real estate transactions and commercial litigation matters.